News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,151 Results
Type
Article (40483)
Company Profile (265)
Press Release (672396)
Multimedia
Podcasts (72)
Webinars (17)
Section
Business (204496)
Career Advice (2017)
Deals (35482)
Drug Delivery (100)
Drug Development (81255)
Employer Resources (173)
FDA (16320)
Job Trends (14922)
News (345967)
Policy (32684)
Tag
Academia (2558)
Accelerated approval (15)
Adcomms (24)
Allergies (115)
Alliances (49575)
ALS (134)
Alzheimer's disease (1558)
Antibody-drug conjugate (ADC) (219)
Approvals (16419)
Artificial intelligence (395)
Autoimmune disease (82)
Automation (29)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (150)
Biotechnology (175)
Bladder cancer (130)
Brain cancer (45)
Breast cancer (485)
Cancer (3799)
Cardiovascular disease (309)
Career advice (1698)
Career pathing (33)
CAR-T (225)
CDC (42)
Cell therapy (603)
Cervical cancer (31)
Clinical research (68180)
Collaboration (1304)
Company closure (4)
Compensation (913)
Complete response letters (43)
COVID-19 (2679)
CRISPR (73)
C-suite (560)
Cystic fibrosis (129)
Data (4608)
Decentralized trials (2)
Denatured (23)
Depression (93)
Diabetes (421)
Diagnostics (6537)
Digital health (33)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (183)
Drug pricing (156)
Drug shortages (28)
Duchenne muscular dystrophy (192)
Earnings (88876)
Editorial (45)
Employer branding (21)
Employer resources (151)
Events (115374)
Executive appointments (924)
FDA (18753)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (1188)
Gene editing (159)
Generative AI (31)
Gene therapy (480)
GLP-1 (869)
Government (4602)
Grass and pollen (5)
Guidances (362)
Healthcare (18855)
HIV (42)
Huntington's disease (36)
IgA nephropathy (59)
Immunology and inflammation (202)
Immuno-oncology (17)
Indications (57)
Infectious disease (2901)
Inflammatory bowel disease (173)
Inflation Reduction Act (13)
Influenza (92)
Intellectual property (188)
Interviews (315)
IPO (16611)
IRA (48)
Job creations (3639)
Job search strategy (1427)
Kidney cancer (15)
Labor market (73)
Layoffs (534)
Leadership (27)
Legal (7937)
Liver cancer (85)
Longevity (11)
Lung cancer (545)
Lymphoma (260)
Machine learning (29)
Management (59)
Manufacturing (587)
MASH (134)
Medical device (13622)
Medtech (13645)
Mergers & acquisitions (19750)
Metabolic disorders (1036)
Multiple sclerosis (132)
NASH (16)
Neurodegenerative disease (199)
Neuropsychiatric disorders (49)
Neuroscience (2512)
NextGen: Class of 2025 (6516)
Non-profit (4493)
Now hiring (59)
Obesity (485)
Opinion (240)
Ovarian cancer (135)
Pain (151)
Pancreatic cancer (167)
Parkinson's disease (226)
Partnered (28)
Patents (403)
Patient recruitment (315)
Peanut (52)
People (58231)
Pharmaceutical (63)
Pharmacy benefit managers (24)
Phase I (21224)
Phase II (30003)
Phase III (22377)
Pipeline (2704)
Policy (247)
Postmarket research (2564)
Preclinical (9038)
Press Release (64)
Prostate cancer (191)
Psychedelics (42)
Radiopharmaceuticals (256)
Rare diseases (602)
Real estate (5936)
Recruiting (69)
Regulatory (23481)
Reports (51)
Research institute (2352)
Resumes & cover letters (351)
Rett syndrome (15)
RNA editing (11)
RSV (67)
Schizophrenia (126)
Series A (193)
Series B (148)
Service/supplier (11)
Sickle cell disease (74)
Special edition (20)
Spinal muscular atrophy (149)
Sponsored (35)
Startups (3599)
State (2)
Stomach cancer (14)
Supply chain (93)
Tariffs (79)
The Weekly (47)
Vaccines (905)
Venture capital (63)
Weight loss (314)
Women's health (55)
Worklife (17)
Date
Today (119)
Last 7 days (644)
Last 30 days (2604)
Last 365 days (30463)
2025 (25043)
2024 (35218)
2023 (40076)
2022 (51174)
2021 (55711)
2020 (54083)
2019 (46538)
2018 (35019)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29266)
2010 (27328)
Location
Africa (729)
Alabama (71)
Alaska (7)
Arizona (270)
Arkansas (13)
Asia (38678)
Australia (6321)
California (9265)
Canada (2835)
China (854)
Colorado (388)
Connecticut (397)
Delaware (261)
Europe (83300)
Florida (1385)
Georgia (300)
Hawaii (2)
Idaho (60)
Illinois (714)
India (48)
Indiana (450)
Iowa (18)
Japan (317)
Kansas (119)
Kentucky (34)
Louisiana (18)
Maine (68)
Maryland (1211)
Massachusetts (6749)
Michigan (282)
Minnesota (536)
Mississippi (4)
Missouri (110)
Montana (29)
Nebraska (25)
Nevada (103)
New Hampshire (72)
New Jersey (2554)
New Mexico (28)
New York (2512)
North Carolina (1251)
North Dakota (8)
Northern California (4314)
Ohio (283)
Oklahoma (20)
Oregon (37)
Pennsylvania (1953)
Puerto Rico (19)
Rhode Island (43)
South America (1100)
South Carolina (48)
South Dakota (1)
Southern California (3563)
Tennessee (148)
Texas (1433)
United States (33567)
Utah (273)
Virginia (219)
Washington D.C. (77)
Washington State (771)
West Virginia (4)
Wisconsin (78)
Wyoming (1)
713,151 Results for "medicinova inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MediciNova to Present at the LD Micro Main Event XIX Investor Conference
October 7, 2025
·
4 min read
Press Releases
MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial
August 26, 2025
·
5 min read
Press Releases
MediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 3, 2025
·
4 min read
Press Releases
MediciNova Announces Poster Presentation of COMBAT-ALS Clinical Trial at the 36th International Symposium on ALS/MND
September 17, 2025
·
4 min read
Press Releases
MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)
September 23, 2025
·
6 min read
Press Releases
MediciNova Provides Enrollment Update for Ongoing ALS and Hypertriglyceridemia Clinical Trials
July 24, 2025
·
6 min read
Press Releases
MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025
April 15, 2025
·
4 min read
Business
MediciNova Chief Business Officer David H. Crean, Ph.D. Assumes Communications Role Overseeing Investor Engagement and Public Relations
MediciNova, Inc. announces that its Chief Business Officer, David H. Crean, Ph.D., will assume management of the Company’s investor engagement, corporate communications, and public relations activities.
June 20, 2024
·
5 min read
Biotech Beach
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer
MediciNova, Inc. announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-166 for the prevention of metastasis of eye cancer.
May 20, 2024
·
6 min read
Biotech Beach
MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-166 (ibudilast)
MediciNova, Inc. announced that it has received an issue notification from the U.S. Patent and Trademark Office for a new patent which covers extended-release oral formulations of MN-166.
May 7, 2024
·
4 min read
1 of 71,316
Next
